Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Efe Eworuke

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Pharmacoepidemiology and Drug Safety|October 17, 2024
Dexamethasone Dose for COVID-19 in a Large U.S. Hospital Network From April 2020 to May 2023Marie C Bradley, Ashish Rai, Austin Cosgrove, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 16, 2020
Risk of Psychiatric Adverse Events Among Montelukast UsersVeronica Sansing-Foster, Nicole Haug, Andrew Mosholder, et al.
Pharmacoepidemiology and Drug Safety|September 18, 2024
Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and DenmarkEfe Eworuke, Mayura U Shinde, Laura Hou, et al.
BMJ Open|April 17, 2023
Valsartan, Losartan and Irbesartan use in the USA, UK, Canada and Denmark after the nitrosamine recalls: a descriptive cohort studyEfe Eworuke, Mayura Shinde, Laura Hou, et al.
American Journal of Epidemiology|February 22, 2021
A General Propensity Score for Signal Identification Using Tree-Based Scan StatisticsShirley V Wang, Judith C Maro, Joshua J Gagne, et al.
Journal of General Internal Medicine|October 2, 2021
Risk of Covid-19-Related Hospitalization and More Severe Outcomes in Medicare Beneficiaries Treated with Renin-Angiotensin-Aldosterone System Inhibitors for HypertensionDavid J Graham, Hector S Izurieta, Stella G Muthuri, et al.
Regulatory Toxicology and Pharmacology : RTP|September 2, 2023
Biosimilars approvals by thirteen regulatory authorities: A cross-national comparisonFernanda Lacerda da Silva Machado, Martín Cañás, Svetlana V Doubova, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Pharmacoepidemiology and Drug Safety|October 17, 2024
Dexamethasone Dose for COVID-19 in a Large U.S. Hospital Network From April 2020 to May 2023Marie C Bradley, Ashish Rai, Austin Cosgrove, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 16, 2020
Risk of Psychiatric Adverse Events Among Montelukast UsersVeronica Sansing-Foster, Nicole Haug, Andrew Mosholder, et al.
Pharmacoepidemiology and Drug Safety|September 18, 2024
Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and DenmarkEfe Eworuke, Mayura U Shinde, Laura Hou, et al.
BMJ Open|April 17, 2023
Valsartan, Losartan and Irbesartan use in the USA, UK, Canada and Denmark after the nitrosamine recalls: a descriptive cohort studyEfe Eworuke, Mayura Shinde, Laura Hou, et al.
American Journal of Epidemiology|February 22, 2021
A General Propensity Score for Signal Identification Using Tree-Based Scan StatisticsShirley V Wang, Judith C Maro, Joshua J Gagne, et al.
Journal of General Internal Medicine|October 2, 2021
Risk of Covid-19-Related Hospitalization and More Severe Outcomes in Medicare Beneficiaries Treated with Renin-Angiotensin-Aldosterone System Inhibitors for HypertensionDavid J Graham, Hector S Izurieta, Stella G Muthuri, et al.
Regulatory Toxicology and Pharmacology : RTP|September 2, 2023
Biosimilars approvals by thirteen regulatory authorities: A cross-national comparisonFernanda Lacerda da Silva Machado, Martín Cañás, Svetlana V Doubova, et al.
Pageof 5